Search

Search Constraints

You searched for: Author/Creator Merlini, G.

Search Results

1. [PP.33.16] IN RESTRICTIVE CARDIOMYOPATHY CAUSED BY CARDIAC AL AMYLOIDOSIS A RESTRICTIVE LV FILLING PATTERN IS ONLY PRESENT IN A MINORITY OF PATIENTS. (September 2016)

2. Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial. (29th May 2020)

3. OP0074 First Report of Circulating Micrornas in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS). (23rd January 2014)

4. P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE. (23rd June 2022)

5. P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022)

6. P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022)

7. THU0376 Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). (23rd January 2014)